指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者静脉血栓栓塞症的预防、诊断与治疗:CHEST指南与专家小组报告

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.
指南 / 共识 · Chest · 2020-06-02
一句话结论CHEST专家小组基于13个PICO问题、22条声明,就COVID-19患者VTE预防、诊断与治疗给出指导,但COVID-19人群证据极少,多数基于专家共识。

该CHEST指南与专家小组报告针对COVID-19患者静脉血栓栓塞症(VTE)的预防、诊断与治疗,通过PICO格式提出13个关键临床问题,系统检索MEDLINE、Embase和Cochrane对照试验注册库,采用验证过的评估工具对证据分级;无证据时采用改良德尔菲法共识形成指导。共产生22条声明。COVID-19人群中证据极少,专家小组因此使用专家共识和现有循证指南制定指导声明。结论指出,COVID-19患者VTE最佳预防、诊断和治疗策略的证据稀疏但快速演变。

要点

  • 该指南针对COVID-19患者VTE的预防、诊断与治疗,基于13个PICO问题形成22条声明。
  • COVID-19人群中证据极少,专家小组使用专家共识和现有循证指南制定指导声明。
  • 无证据时采用改良德尔菲法共识形成指导。
  • 证据稀疏但快速演变,临床决策需结合现有循证指南与专家共识。

适用人群与场景

  • COVID-19患者(严重者可并发显著凝血病,可能表现为微血栓和VTE)。

研究设计与关键结果

  • 系统评价与文献批判性分析基于13个PICO问题,产生22条声明。
  • COVID-19人群中证据极少,专家小组使用专家共识和现有循证指南制定指导声明。
  • 无证据时采用改良德尔菲法共识形成指导。

证据类型、等级与局限

  • 证据类型:指南与专家小组报告;采用验证过的评估工具对证据分级,无证据时基于改良德尔菲法共识。
  • 局限:COVID-19人群中证据极少;证据稀疏但快速演变。

对床旁实践的改变

  • 对COVID-19患者VTE的预防、诊断与治疗,可参照该CHEST指南与专家小组报告形成的22条声明;因COVID-19人群证据极少,多数指导基于专家共识和现有循证指南。

指南或共识出处

  • CHEST Guideline and Expert Panel Report: Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of VTE.

METHODS: A group of approved panelists developed key clinical questions by using the PICO (Population, Intervention, Comparator, Outcome) format that addressed urgent clinical questions regarding the prevention, diagnosis, and treatment of VTE in patients with COVID-19. MEDLINE (via PubMed or Ovid), Embase, and Cochrane Controlled Register of Trials were systematically searched for relevant literature, and references were screened for inclusion. Validated evaluation tools were used to grade the level of evidence to support each recommendation. When evidence did not exist, guidance was developed based on consensus using the modified Delphi process.

RESULTS: The systematic review and critical analysis of the literature based on 13 Population, Intervention, Comparator, Outcome questions resulted in 22 statements. Very little evidence exists in the COVID-19 population. The panel thus used expert consensus and existing evidence-based guidelines to craft the guidance statements.

CONCLUSIONS: The evidence on the optimal strategies to prevent, diagnose, and treat VTE in patients with COVID-19 is sparse but rapidly evolving.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020. PMID: 32502594. doi:10.1016/j.chest.2020.05.559

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。